Riding High And Scaling Up, Chindex Readies Business Model Rollout In China
This article was originally published in PharmAsia News
Executive Summary
American hospital operator and medical device distributor Chindex is riding strong midterm growth momentum built on its strong branding in China and will likely benefit hugely from China's healthcare reforms and growing middle class.
You may also be interested in...
Shanghai Fosun And Chindex CEO Team Up To Capitalize On China’s Growing Private Markets
As China opens up its private hospital market and a new wave of investment, major players such as Chindex International Inc. are reevaluating and repositioning themselves to benefit from the growing private infrastructure.
China’s Healthcare Reform Needs Resource Allocation Shift – Healthcare Officials
Fundamental shift in resource allocation, physician incentive systems and reforms to public hospitals critical say key healthcare officials.
China’s Healthcare Reform Needs Resource Allocation Shift – Healthcare Officials
Fundamental shift in resource allocation, physician incentive systems and reforms to public hospitals critical say key healthcare officials.